OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: Superfluid Dx

2 Projects | 2 Researchers | $2,731,676 Invested

2025

Superfluid Dx

Bojk Berghuis

Integrating cfRNA and Proteomics with AI for Next-Generation Alzheimer’s Diagnostics

  • Funding Amount: $911,250
  • Organization Type:
  • Program: Diagnostics Accelerator
  • Target: Other
  • Status: Active

2022

Superfluid Dx

John Sninsky, PhD

Development of cell free messenger RNA-based non-invasive diagnostic biomarker for Alzheimer's disease

  • Funding Amount: $1,820,426
  • Organization Type: Biotechnology/For Profit
  • Program: Diagnostics Accelerator
  • Target: Other
  • Status: Closed